MSB 11.8% $1.57 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-304

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 596 Posts.
    lightbulb Created with Sketch. 128
    Re the Covid trial, just wondering regarding some of the secondary outcomes such as if patient is still alive after 90 days after the treatment. So if the trial goes the full distance potentially the full results will not be released till march - april?. Or is it possible they would release the results of just the primary outcome, then release secondary outcomes later. I am assuming that they would release primary outcome first then secondary outcomes later given the emergency?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.792B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 39613 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.